Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Non-alcoholic Fatty Liver Disease

fluorobenzenes has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Black, CA; Fleming, JW; Malinowski, SS; Miller, KH; Riche, DM; Wofford, MR1
Athyros, VG; Giouleme, O; Karagiannis, A; Kargiotis, K; Katsiki, E; Katsiki, N; Mikhailidis, DP; Patsiaoura, K1
Barabanchyk, OV; Kozak, NP; Svintsits'kyĭ, AS1
Dubrovins'ka, TV; Skrypnyk, IM1
Aguila, MB; Fraulob, JC; Mandarim-de-Lacerda, CA; Souza-Mello, V1
Itoh, Y; Jo, M; Kagawa, K; Kimura, H; Minami, M; Mitsumoto, Y; Mitsuyoshi, H; Nakajima, T; Nishikawa, T; Nishimura, T; Okada, Y; Okanoue, T; Tochiki, N; Yamaguchi, K; Yasui, K1

Trials

2 trial(s) available for fluorobenzenes and Non-alcoholic Fatty Liver Disease

ArticleYear
Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report.
    Current vascular pharmacology, 2014, Volume: 12, Issue:3

    Topics: Adult; Biopsy; Drug Administration Schedule; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Liver Function Tests; Male; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors

2014
[Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
    Georgian medical news, 2014, Issue:229

    Topics: Atorvastatin; Bilirubin; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipids; Liver; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Transaminases; Triglycerides; Ursodeoxycholic Acid

2014

Other Studies

5 other study(ies) available for fluorobenzenes and Non-alcoholic Fatty Liver Disease

ArticleYear
Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:1

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, Combination; Dyslipidemias; Fatty Liver; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones

2014
[CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA].
    Likars'ka sprava, 2014, Issue:11

    Topics: Adult; Allopurinol; Bile; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Cholesterol; Cholic Acid; Deoxycholic Acid; Drug Therapy, Combination; Duodenoscopy; Female; Fluorobenzenes; Humans; Hyperuricemia; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Taurocholic Acid; Uric Acid; Ursodeoxycholic Acid

2014
[Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis].
    Likars'ka sprava, 2014, Issue:11

    Topics: Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides; Triglycerides

2014
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
    Clinical science (London, England : 1979), 2012, Aug-01, Volume: 123, Issue:4

    Topics: Adipokines; Adipose Tissue; Adiposity; Animals; Blood Glucose; Body Composition; Diet, High-Fat; Fatty Liver; Fluorobenzenes; Homeostasis; Insulin Resistance; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Pyrimidines; Resistin; Rosiglitazone; Rosuvastatin Calcium; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Thiazolidinediones; Triglycerides

2012
Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:2

    Topics: Acyl-CoA Dehydrogenase, Long-Chain; Acyl-CoA Oxidase; Alanine Transaminase; Animals; Azo Compounds; Carnitine O-Palmitoyltransferase; Catalase; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; DNA Primers; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Nonesterified; Fatty Liver; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Liver; Male; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides

2013